This survey showed low rates of HBV chronic infection in HIV-infected and uninfected children living in a RLS of KZN province. The vertical and horizontal transmissions before 5 years of age decreased in both cohorts since the introduction of the HBV vaccine. Due to their weaker immune system, HIV-infected children had lower anti-HBs rates than the HIV-uninfected patients. Without establishing regular monitoring of their immunity and adaptation of the vaccine schedule, prevalence of HBV could stay high in SA despite optimal vaccination coverage in HIV-infected patients. 1.World Health Organization, 2014. HIV/AIDS (Accessed January 2016). http://www.who.int/hiv/en/ 2.Phung BC, Sogni P, Launay O. 2014 Hepatitis B and human immunodeficiency vi...
Introduction and methodsHepatitis B is a vaccine preventable disease and is notifiable in South Afri...
Hepatitis B is a global public health issue, with some 2 billion people having current or past infec...
Abstract Background Whilst much attention is given to...
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccinati...
The study evaluated and compared the prevalence of anti-HBs and exposure to hepatitis B virus (HBV) ...
Background In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a po...
AbstractBackgroundIn South Africa, the first HBV vaccine dose is administered at age 6 weeks, leavin...
AbstractHepatitis B virus infection (HBV) is a significant public health problem in sub-Saharan Afri...
BackgroundBotswana introduced the HBV vaccine at birth for all newborns in 2000. To the best of our ...
Background HIV-infected children have a lower seroconversion rate to hepatitis B virus (HBV) immuni...
Objective To evaluate the effectiveness of universal vaccination against viral hepatitis B in South ...
BACKGROUND:Since 2005, anti-hepatitis B virus (anti-HBV) vaccine is part of the Expanded Program on ...
Background: HIV/HBV co-infection remains a global threat to HIV management despite the available eff...
Despite being vaccine-preventable, hepatitis B virus (HBV) infection remains the seventh leading cau...
Objective. Hepatitis B virus (HBV) and HIV are endemic infections in many African countries. The obj...
Introduction and methodsHepatitis B is a vaccine preventable disease and is notifiable in South Afri...
Hepatitis B is a global public health issue, with some 2 billion people having current or past infec...
Abstract Background Whilst much attention is given to...
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccinati...
The study evaluated and compared the prevalence of anti-HBs and exposure to hepatitis B virus (HBV) ...
Background In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a po...
AbstractBackgroundIn South Africa, the first HBV vaccine dose is administered at age 6 weeks, leavin...
AbstractHepatitis B virus infection (HBV) is a significant public health problem in sub-Saharan Afri...
BackgroundBotswana introduced the HBV vaccine at birth for all newborns in 2000. To the best of our ...
Background HIV-infected children have a lower seroconversion rate to hepatitis B virus (HBV) immuni...
Objective To evaluate the effectiveness of universal vaccination against viral hepatitis B in South ...
BACKGROUND:Since 2005, anti-hepatitis B virus (anti-HBV) vaccine is part of the Expanded Program on ...
Background: HIV/HBV co-infection remains a global threat to HIV management despite the available eff...
Despite being vaccine-preventable, hepatitis B virus (HBV) infection remains the seventh leading cau...
Objective. Hepatitis B virus (HBV) and HIV are endemic infections in many African countries. The obj...
Introduction and methodsHepatitis B is a vaccine preventable disease and is notifiable in South Afri...
Hepatitis B is a global public health issue, with some 2 billion people having current or past infec...
Abstract Background Whilst much attention is given to...